Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 522

1.

Pilot study of oral montelukast added to standard therapy for acute asthma exacerbations in children aged 6 to 14 years.

Nelson KA, Smith SR, Trinkaus K, Jaffe DM.

Pediatr Emerg Care. 2008 Jan;24(1):21-7. doi: 10.1097/pec.0b013e31815f3968.

PMID:
18165796
3.

A randomized, placebo-controlled study of intravenous montelukast in children with acute asthma.

Morris CR, Becker AB, Piñieiro A, Massaad R, Green SA, Smugar SS, Gurner DM.

Ann Allergy Asthma Immunol. 2010 Feb;104(2):161-71.

PMID:
20306820
4.

The efficacy of montelukast during the allergy season in pediatric patients with persistent asthma and seasonal aeroallergen sensitivity.

Papadopoulos NG, Philip G, Giezek H, Watkins M, Smugar SS, Polos PG.

J Asthma. 2009 May;46(4):413-20. doi: 10.1080/02770900902847727. Erratum in: J Asthma. 2009 Oct;46(8):858.

PMID:
19484680
5.

Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group.

Malmstrom K, Rodriguez-Gomez G, Guerra J, Villaran C, Piñeiro A, Wei LX, Seidenberg BC, Reiss TF.

Ann Intern Med. 1999 Mar 16;130(6):487-95.

PMID:
10075616
6.
7.

Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients.

Dockhorn RJ, Baumgartner RA, Leff JA, Noonan M, Vandormael K, Stricker W, Weinland DE, Reiss TF.

Thorax. 2000 Apr;55(4):260-5.

8.

Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older.

Williams B, Noonan G, Reiss TF, Knorr B, Guerra J, White R, Matz J.

Clin Exp Allergy. 2001 Jun;31(6):845-54.

PMID:
11422148
9.

A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma.

Camargo CA Jr, Gurner DM, Smithline HA, Chapela R, Fabbri LM, Green SA, Malice MP, Legrand C, Dass SB, Knorr BA, Reiss TF.

J Allergy Clin Immunol. 2010 Feb;125(2):374-80. doi: 10.1016/j.jaci.2009.11.015.

PMID:
20159247
10.

Montelukast in asthmatic patients 6 years-14 years old with an FEV1 > 75%.

Becker A, Swern A, Tozzi CA, Yu Q, Reiss T, Knorr B.

Curr Med Res Opin. 2004 Oct;20(10):1651-9.

PMID:
15462699
12.

Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.

Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.

Clin Ther. 2008 Aug;30(8):1492-504. doi: 10.1016/j.clinthera.2008.07.018.

PMID:
18803991
13.

Montelukast: a review of its therapeutic potential in persistent asthma.

Jarvis B, Markham A.

Drugs. 2000 Apr;59(4):891-928. Review.

PMID:
10804041
14.

Effects of oral montelukast on airway function in acute asthma.

Cýllý A, Kara A, Ozdemir T, Oğüş C, Gülkesen KH.

Respir Med. 2003 May;97(5):533-6.

PMID:
12735671
15.

Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma.

Vaquerizo MJ, Casan P, Castillo J, Perpiña M, Sanchis J, Sobradillo V, Valencia A, Verea H, Viejo JL, Villasante C, Gonzalez-Esteban J, Picado C; CASIOPEA (Capacidad de Singulair Oral en la Prevencion de Exacerbaciones Asmaticas) Study Group..

Thorax. 2003 Mar;58(3):204-10. Erratum in: Thorax. 2003 Apr;58(4):370.

16.

The efficacy and tolerability of intravenous montelukast in acute asthma exacerbations in Japanese patients.

Adachi M, Taniguchi H, Tohda Y, Sano Y, Ishine T, Smugar SS, Hisada S.

J Asthma. 2012 Aug;49(6):649-56. doi: 10.3109/02770903.2012.690479.

PMID:
22742205
17.

Oral montelukast treatment of preschool-aged children with acute asthma.

Harmanci K, Bakirtas A, Turktas I, Degim T.

Ann Allergy Asthma Immunol. 2006 May;96(5):731-5.

PMID:
16729788
18.

Analysis of montelukast in mild persistent asthmatic patients with near-normal lung function.

Barnes N, Wei LX, Reiss TF, Leff JA, Shingo S, Yu C, Edelman JM.

Respir Med. 2001 May;95(5):379-86. Review.

19.

Spotlight on montelukast in asthma in children 2 to 14 years of age.

Muijsers RB, Noble S.

Am J Respir Med. 2002;1(3):225-8. Review.

PMID:
14720060
20.

Effect of montelukast, a once-daily leukotriene receptor antagonist, on peak expiratory flow variability.

Zhang J, Yu C, Noonan G, Reiss TF.

Clin Ther. 2002 Apr;24(4):574-82.

PMID:
12017402
Items per page

Supplemental Content

Support Center